health care cost

Research in Review

Decreasing TKI Dosage Provides Better Outcomes in CML, Lowers Costs

06/29/2017

JCP Editors

Patients with chronic myeloid leukemia (CML) who receive half the standard dose of tyrosine kinase inhibitor (TKI) therapy are likely to eliminate most adverse events, drastically reduce costs, and improve...

...

06/29/2017

Journal of Clinical Pathways

Research in Review

High Cost of Care for Older Patients With Brain Tumors at EOL

06/23/2017

JCP Editors

Hospital-based end-of-life (EOL) care for older patients with malignant brain tumors is associated with over $16,000 in expenses per patient, according to a research letter published in JAMA Oncology (published...

...

06/23/2017

Journal of Clinical Pathways

Interview

Estimating Real Costs of Care for Different Cancers, Insurance Types

06/12/2017

JCP Editors

A report from the American Cancer Society Cancer Action Network (ACS CAN) estimated the total costs to patients associated with cancer diagnoses and treatment, based on their type of insurance. ----- Related...

A...

06/12/2017

Journal of Clinical Pathways

Research in Review

B-Cell Malignancy Provides Economic Burden to US Commercial Payers

05/30/2017

JCP Editors

The high economic burden of B-cell malignancies on US commercial insurers may impact future reimbursement decisions, according to research that will be presented at the 2017 ASCO Annual Meeting (June 2-6, 2017;...

The...

05/30/2017

Journal of Clinical Pathways

Department

Cancer Patients Unfamiliar With Clinical Practice Guidelines, Clinical Pathways

04/12/2017

JCP Editors

Results of a recent survey of the cancer care experience revealed barriers to navigating cancer care, including high costs and lack of information about how treatment decisions are made. ----- Related...

...

04/12/2017

Journal of Clinical Pathways

Department

Colon Cancer Costs Continue Rising

03/15/2017

JCP Editors

The cost of colon cancer care rose significantly during the period from 2003 to 2013, despite decreases in overall hospitalizations and lengths of stay. ----- Related Content Adjuvant Chemotherapy Improves Colon...

The...

03/15/2017

Journal of Clinical Pathways

Research in Review

COST Tool Measures Financial Toxicity of Patient Cancer Treatment

10/14/2016

JCP Editors

Cancer and its treatments lead to financial toxicity for patients, according to cancer specialists who reported the findings from using the Comprehensive Score for Financial Toxicity (COST) questionnaire in Cancer....

Cancer...

10/14/2016

Journal of Clinical Pathways

Research in Review

Study Identifies Financial Ties Among NCCN Guideline Authors and Drug Industry

09/02/2016

JCP Editors

A new study that quantifies industry financial conflicts of interest (FCOIs) found that nearly nine out of 10 physicians and researchers who helped develop the National Comprehensive Network (NCCN) guidelines—work...

A new...

09/02/2016

Journal of Clinical Pathways

Research in Review

Value for US Cancer Drug Spending Lags Behind Other Nations

05/03/2016

JCP Editors

A study of international cancer care costs has revealed that the value of US cancer drug spending has not kept pace with that of other nations in terms of health gains per dollar spent. Sebastian Salas-Vega, MSc,...

A...

05/03/2016

Journal of Clinical Pathways

Revealing Treatment Costs at the Point of Care Beneficial to Patients and Providers

03/08/2016

JCP Editors

A tool integrating costs associated with common cancer treatments with electronic medical records was beneficial to both physicians and patients, according to results of a study presented at the conference. Patients...

A tool...

03/08/2016

Journal of Clinical Pathways